Northeast Pharmaceutical Group Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000009G0
  • SHE: 000597
CNY
4.83
-0.06 (-1.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

The company is Net-Debt Free

  • Poor long term growth as Net Sales has grown by an annual rate of -0.84% and Operating profit at 4.58% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Equity (avg) of 5.42% signifying low profitability per unit of shareholders funds
2

Poor long term growth as Net Sales has grown by an annual rate of -0.84% and Operating profit at 4.58% over the last 5 years

 
3

The company has declared negative results for the last 5 consecutive quarters

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 7,178 Million (Mid Cap)

stock-summary
P/E

30.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.08%

stock-summary
Debt Equity

0.04

stock-summary
Return on Equity

3.61%

stock-summary
Price to Book

1.29

Revenue and Profits:
Net Sales:
1,327 Million
(Quarterly Results - Jun 2026)
Net Profit:
47 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
9.77%
0%
9.77%
6 Months
-5.29%
0%
-5.29%
1 Year
-12.02%
0%
-12.02%
2 Years
17.52%
0%
17.52%
3 Years
-6.94%
0%
-6.94%
4 Years
-0.21%
0%
-0.21%
5 Years
-13.75%
0%
-13.75%

Northeast Pharmaceutical Group Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-0.84%
EBIT Growth (5y)
4.58%
EBIT to Interest (avg)
4.22
Debt to EBITDA (avg)
1.66
Net Debt to Equity (avg)
0.20
Sales to Capital Employed (avg)
0.72
Tax Ratio
25.49%
Dividend Payout Ratio
30.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.56%
ROE (avg)
5.42%

Valuation key factors

Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
1.08
EV to EBIT
26.15
EV to EBITDA
9.70
EV to Capital Employed
1.08
EV to Sales
0.87
PEG Ratio
NA
Dividend Yield
1.29%
ROCE (Latest)
4.11%
ROE (Latest)
3.61%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -33.87% vs 25.64% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 189.02% vs -71.13% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,326.80",
          "val2": "2,006.20",
          "chgp": "-33.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "183.50",
          "val2": "160.40",
          "chgp": "14.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.70",
          "val2": "10.60",
          "chgp": "-17.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.00",
          "val2": "-3.00",
          "chgp": "200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "47.40",
          "val2": "16.40",
          "chgp": "189.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "42.80%",
          "val2": "16.80%",
          "chgp": "2.60%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -5.69% vs -8.52% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -48.55% vs 12.58% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,041.10",
          "val2": "7,466.00",
          "chgp": "-5.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "802.80",
          "val2": "1,060.30",
          "chgp": "-24.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "82.50",
          "val2": "112.50",
          "chgp": "-26.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-37.40",
          "val2": "-37.20",
          "chgp": "-0.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "217.80",
          "val2": "423.30",
          "chgp": "-48.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.90%",
          "val2": "65.30%",
          "chgp": "-2.94%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
1,326.80
2,006.20
-33.87%
Operating Profit (PBDIT) excl Other Income
183.50
160.40
14.40%
Interest
8.70
10.60
-17.92%
Exceptional Items
3.00
-3.00
200.00%
Consolidate Net Profit
47.40
16.40
189.02%
Operating Profit Margin (Excl OI)
42.80%
16.80%
2.60%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is -33.87% vs 25.64% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 189.02% vs -71.13% in Mar 2026

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
7,041.10
7,466.00
-5.69%
Operating Profit (PBDIT) excl Other Income
802.80
1,060.30
-24.29%
Interest
82.50
112.50
-26.67%
Exceptional Items
-37.40
-37.20
-0.54%
Consolidate Net Profit
217.80
423.30
-48.55%
Operating Profit Margin (Excl OI)
35.90%
65.30%
-2.94%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is -5.69% vs -8.52% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -48.55% vs 12.58% in Dec 2024

stock-summaryCompany CV
About Northeast Pharmaceutical Group Co., Ltd. stock-summary
stock-summary
Northeast Pharmaceutical Group Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available